2,4,5-trihydroxyamphetamine has been researched along with methyldopa in 1 studies
| Studies (2,4,5-trihydroxyamphetamine) | Trials (2,4,5-trihydroxyamphetamine) | Recent Studies (post-2010) (2,4,5-trihydroxyamphetamine) | Studies (methyldopa) | Trials (methyldopa) | Recent Studies (post-2010) (methyldopa) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 3,719 | 420 | 143 |
| Protein | Taxonomy | 2,4,5-trihydroxyamphetamine (IC50) | methyldopa (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 5.228 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 5.176 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.126 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castagnoli, N; Cheng, A; Karashima, D; Melmon, KL; Musson, DG; Rubiero, H | 1 |
1 other study(ies) available for 2,4,5-trihydroxyamphetamine and methyldopa
| Article | Year |
|---|---|
Synthetic and preliminary hemodynamic and whole animal toxicity studies on (R,S)-, (R)-, and (S)-2-methyl-3-(2,4,5-trihydroxyphenyl)alanine.
Topics: Animals; Blood Pressure; Chemical Phenomena; Chemistry; Hemodynamics; Lethal Dose 50; Male; Methyldopa; Mice; Molecular Conformation; Rats; Stereoisomerism; Structure-Activity Relationship | 1980 |